Unknown

Dataset Information

HSPB5 suppresses renal inflammation and protects lupus-prone NZB/W F1 mice from severe renal damage.


ABSTRACT:

Background

Lupus nephritis (LN) is an inflammatory disease of the kidneys affecting patients with systemic lupus erythematosus. Current immunosuppressive and cytotoxic therapies are associated with serious side effects and fail to protect 20-40% of LN patients from end-stage renal disease. In this study, we investigated whether a small heat shock protein, HSPB5, can reduce kidney inflammation and the clinical manifestations of the disease in NZB/W F1 mice. Furthermore, we investigated whether HSPB5 can enhance the effects of methylprednisolone, a standard-of-care drug in LN, in an endotoxemia mouse model.

Methods

NZB/W F1 mice were treated with HSPB5, methylprednisolone, or vehicle from 23 to 38 weeks of age. Disease progression was evaluated by weekly proteinuria scores. At

SUBMITTER: Knapp J 

PROVIDER: S-EPMC9743758 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature